BioElectronics Corporation announced that it has appointed Evomed as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole Heel Pain Relief Therapy in Australia and New Zealand. Evomed will also be promoting the ActiPatch 7-Day Trial Device to assist chronic pain sufferers with an affordable way to trial the device.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -50.00% |
03-25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
02-23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 4.94M | |
+11.31% | 225B | |
+15.50% | 197B | |
+18.83% | 143B | |
+30.38% | 111B | |
+2.62% | 64.72B | |
+18.31% | 54.44B | |
+4.96% | 51.06B | |
+9.95% | 45.03B | |
+4.27% | 37.4B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics Corporation Appoints Evomed as Australian and New Zealand Distributor